Finance

Lists
301230:SHE
PharmaResources (Shanghai) Co Ltd
CNÂ¥28.28
-3.71%
(-1.09) 1D
Sep 11, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301230...
Open
CNÂ¥29.01
High
CNÂ¥29.18
Low
CNÂ¥27.64
Mkt. cap
5.12B
Avg. vol.
18.87M
Volume
12.06M
Dividend
1.01%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
135.01
52-wk high
CNÂ¥52.28
52-wk low
CNÂ¥22.23
EPS
CNÂ¥0.21
Shares outstanding
180.94M
No. of employees
1K
Open
CNÂ¥29.01
High
CNÂ¥29.18
Low
CNÂ¥27.64
Mkt. cap
5.12B
Avg. vol.
18.87M
Volume
12.06M
Dividend
1.01%
Quarterly dividend
CNÂ¥0.07
Ex-dividend date
Jul 16, 2026
P/E ratio
135.01
52-wk high
CNÂ¥52.28
52-wk low
CNÂ¥22.23
EPS
CNÂ¥0.21
Shares outstanding
180.94M
No. of employees
1K
About PharmaResources (Shanghai) Co Ltd
CEO-
Employees1.3K
FoundedDec 14, 2007
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
161.66M
173.95M
172.29M
192.12M
Cost of goods sold
113.37M
141.40M
117.29M
145.45M
Cost of revenue
113.37M
141.40M
117.29M
145.45M
Research and development expenses
9.80M
8.36M
10.74M
10.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.90M
31.02M
27.59M
29.37M
Operating expense
37.54M
41.00M
38.16M
34.81M
Total operating expenses
150.91M
182.40M
155.45M
180.25M
Operating income
10.75M
-8.45M
16.83M
11.87M
Other non operating income
1.57M
-1.69M
-2.12M
-8.44M
EBT including unusual items
9.15M
-3.51M
25.98M
4.15M
EBT excluding unusual items
8.67M
-11.07M
19.90M
9.88M
Income tax expense
-840.10K
-3.05M
2.21M
-800.39K
Effective tax rate
-9.18%
87.04%
8.49%
-19.29%
Other operating expenses
896.06K
306.17K
327.40K
-5.23M
Net income
9.99M
-454.81K
23.78M
4.95M
Net profit margin
6.18%
-0.26%
13.80%
2.58%
Earnings per share
-
-
-
-
Interest and investment income
288.09K
177.60K
7.10M
6.45M
Interest expense
-2.04M
-1.98M
-1.91M
-
Net interest expenses
-1.75M
-1.80M
5.18M
6.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
17.23M
-1.39M
23.90M
19.46M
Gain or loss from assets sale
-
-41.52K
-
-
AI content may include mistakes. Learn more
Google apps